Abid MB - Search Results

1

Kawasaki like illness due to COVID-19: a review of the literature.

Fang Y, Aravamudan VM, Sridharan GK, Mehta KK, Sekhar R, Senguttuvan NB, Venkatachalam I, Abid MB. Fang Y, et al. Among authors: abid mb. J Infect Dev Ctries. 2021 May 31;15(5):630-638. doi: 10.3855/jidc.14185. J Infect Dev Ctries. 2021. PMID: 34106885 Free article. Review.

2

Overlap of immunotherapy-related pneumonitis and COVID-19 pneumonia: diagnostic and vaccine considerations.

Abid MB. Abid MB. J Immunother Cancer. 2021 Apr;9(4):e002307. doi: 10.1136/jitc-2020-002307. J Immunother Cancer. 2021. PMID: 33931473 Free PMC article.

3

Role of Gut Microbiome in COVID-19: An Insight Into Pathogenesis and Therapeutic Potential.

Hussain I, Cher GLY, Abid MA, Abid MB. Hussain I, et al. Among authors: abid ma, abid mb. Front Immunol. 2021 Oct 14;12:765965. doi: 10.3389/fimmu.2021.765965. eCollection 2021. Front Immunol. 2021. PMID: 34721437 Free PMC article. Review.

4

Mesenteric panniculitis does not confer an increased risk for cancers: A systematic review and meta-analysis.

Hussain I, Ishrat S, Aravamudan VM, Khan SR, Mohan BP, Lohan R, Abid MB, Ang TL. Hussain I, et al. Among authors: abid mb. Medicine (Baltimore). 2022 Apr 29;101(17):e29143. doi: 10.1097/MD.0000000000029143. Medicine (Baltimore). 2022. PMID: 35512070 Free PMC article.

5

Probiotics in health and disease: fooling Mother Nature?

Abid MB, Koh CJ. Abid MB, et al. Infection. 2019 Dec;47(6):911-917. doi: 10.1007/s15010-019-01351-0. Epub 2019 Sep 2. Infection. 2019. PMID: 31478123 Review.

6

Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment.

Abid MB, Mughal M, Abid MA. Abid MB, et al. Among authors: abid ma. JAMA Oncol. 2020 Oct 1;6(10):1529-1530. doi: 10.1001/jamaoncol.2020.2367. JAMA Oncol. 2020. PMID: 32433719 No abstract available.

7

Bronchoalveolar lavage-based COVID-19 testing in patients with cancer.

Abid MB, Chhabra S, Buchan B, Graham MB, Abedin S, Thapa B, D'Souza A, George B, Hamadani M. Abid MB, et al. Hematol Oncol Stem Cell Ther. 2021 Mar;14(1):65-70. doi: 10.1016/j.hemonc.2020.09.002. Epub 2020 Oct 8. Hematol Oncol Stem Cell Ther. 2021. PMID: 33058787 Free PMC article.

8

State of the CAR-T: Risk of Infections with Chimeric Antigen Receptor T-Cell Therapy and Determinants of SARS-CoV-2 Vaccine Responses.

Meir J, Abid MA, Abid MB. Meir J, et al. Among authors: abid ma, abid mb. Transplant Cell Ther. 2021 Dec;27(12):973-987. doi: 10.1016/j.jtct.2021.09.016. Epub 2021 Sep 27. Transplant Cell Ther. 2021. PMID: 34587552 Free PMC article. Review.

9

SARS-CoV-2 vaccine response in CAR T-cell therapy recipients: A systematic review and preliminary observations.

Abid MA, Abid MB. Abid MA, et al. Among authors: abid mb. Hematol Oncol. 2022 Apr;40(2):287-291. doi: 10.1002/hon.2957. Epub 2021 Dec 20. Hematol Oncol. 2022. PMID: 34911142

10

Early immunomodulators with CAR T-cell immunotherapy in the COVID-19 era.

Abid MB. Abid MB. Lancet Oncol. 2022 Jan;23(1):16-18. doi: 10.1016/S1470-2045(21)00695-1. Lancet Oncol. 2022. PMID: 34973215 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

89 results

Search Page